Maternal administration of probiotic or prebiotic prevents male adult rat offspring against developmental programming of hypertension induced by high fructose consumption in pregnancy and lactation

Nutrients

Volumn 10, Issue 9, 2018, Pages

  Hsu, Chien Ning ^a,b   Lin, Yu Ju ^c   Hou, Chih Yao ^d   Tain, You Lin ^c  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d NATIONAL KAOHSIUNG UNIVERSITY OF APPLIED SCIENCES   (Taiwan)

Author keywords

Fructose; Gut microbiota; Hypertension; Nutrient sensing signal; Sensory receptor; Short chain fatty acid

Indexed keywords

ACETIC ACID; BUTYRIC ACID; INULIN; PREBIOTIC AGENT; PROBIOTIC AGENT; PROPIONIC ACID; SHORT CHAIN FATTY ACID; FRUCTOSE; MESSENGER RNA; PROPIONIC ACID DERIVATIVE; VOLATILE FATTY ACID;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CONTROLLED STUDY; FEMALE; FLAME IONIZATION DETECTION; HIGH FAT/HIGH FRUCTOSE DIET; HYPERTENSION; INTESTINE FLORA; KIDNEY MASS; LACTATION; LACTOBACILLUS CASEI; MALE; MASS FRAGMENTOGRAPHY; MATERNAL NUTRITION; MORPHOLOGICAL TRAIT; NEXT GENERATION SEQUENCING; NONHUMAN; PREGNANCY; PROGENY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SENSORY RECEPTOR; SIGNAL TRANSDUCTION; SYSTOLIC BLOOD PRESSURE; WESTERN BLOTTING; ANIMAL; BLOOD; DIET; GENETICS; KIDNEY; METABOLISM; NEWBORN; OLFACTORY RECEPTOR; PRENATAL EXPOSURE; PREVENTION AND CONTROL; SPRAGUE DAWLEY RAT;

ACETATES; ANIMALS; ANIMALS, NEWBORN; BLOOD PRESSURE; DIET; FATTY ACIDS, VOLATILE; FEMALE; FRUCTOSE; GASTROINTESTINAL MICROBIOME; HYPERTENSION; INULIN; KIDNEY; LACTATION; LACTOBACILLUS CASEI; MALE; PREBIOTICS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROBIOTICS; PROPIONATES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ODORANT; RNA, MESSENGER;

EID: 85053076943     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu10091229     Document Type: Article

References (38)

1. Rizkalla, S.W. Health implications of fructose consumption: A review of recent data. Nutr. Metab. 2010, 7, 82. [CrossRef] [PubMed]
2. Regnault, T.R.; Gentili, S.; Sarr, O.; Toop, C.R.; Sloboda, D.M. Fructose, pregnancy and later life impacts. Clin. Exp. Pharmacol. Physiol. 2013, 40, 824–837. [CrossRef] [PubMed]
3. Saad, A.F.; Dickerson, J.; Kechichian, T.B.; Yin, H.; Gamble, P.; Salazar, A.; Patrikeev, I.; Motamedi, M.; Saade, G.R.; Costantine, M.M. High-fructose diet in pregnancy leads to fetal programming of hypertension, insulin resistance, and obesity in adult offspring. Am. J. Obstet. Gynecol. 2016, 215, 378. [CrossRef] [PubMed]
4. Johnson, R.J.; Segal, M.S.; Sautin, Y.; Nakagawa, T.; Feig, D.I.; Kang, D.H.; Gersch, M.S.; Benner, S.; Sánchez-Lozada, L.G. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am. J. Clin. Nutr. 2007, 86, 899–906. [PubMed]
5. Kett, M.M.; Denton, K.M. Renal programming: Cause for concern? Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 300, R791–R803. [CrossRef] [PubMed]
6. Hanson, M. The birth and future health of DOHaD. J. Dev. Orig. Health Dis. 2015, 6, 434–437. [CrossRef] [PubMed]
7. Tain, Y.L.; Wu, K.L.; Lee, W.C.; Leu, S.; Chan, J.Y. Maternal fructose-intake-induced renal programming in adult male offspring. J. Nutr. Biochem. 2015, 26, 642–650. [CrossRef] [PubMed]
8. Tain, Y.L.; Joles, J.A. Reprogramming: A preventive strategy in hypertension focusing on the kidney. Int. J. Mol. Sci. 2015, 17, 23. [CrossRef] [PubMed]
9. Yang, T.; Santisteban, M.M.; Rodriguez, V.; Li, E.; Ahmari, N.; Carvajal, J.M.; Zadeh, M.; Gong, M.; Qi, Y.; Zubcevic, J.; et al. Gut dysbiosis is linked to hypertension. Hypertension 2015, 65, 1331–1340. [CrossRef] [PubMed]
10. Kang, Y.; Cai, Y. Gut microbiota and hypertension: From pathogenesis to new therapeutic strategies. Clin. Res. Hepatol. Gastroenterol. 2018, 42, 110–117. [CrossRef] [PubMed]
11. Galla, S.; Chakraborty, S.; Cheng, X.; Yeo, J.; Mell, B.; Zhang, H.; Mathew, A.V.; Vijay-Kumar, M.; Joe, B. Disparate effects of antibiotics on hypertension. Physiol. Genom. 2018. [CrossRef] [PubMed]
12. Bier, A.; Braun, T.; Khasbab, R.; Di Segni, A.; Grossman, E.; Haberman, Y.; Leibowitz, A. A high salt diet modulates the gut microbiota and short chain fatty acids production in a salt-sensitive hypertension rat model. Nutrients 2018, 10, 1154. [CrossRef] [PubMed]
13. He, M.; Shi, B. Gut microbiota as a potential target of metabolic syndrome: The role of probiotics and prebiotics. Cell Biosci. 2017, 7, 54. [CrossRef] [PubMed]
14. Pluznick, J.L. Renal and cardiovascular sensory receptors and blood pressure regulation. Am. J. Physiol. Renal Physiol. 2013, 305, F439–F444. [CrossRef] [PubMed]
15. Pluznick, J.L. Microbial short-chain fatty acids and blood pressure regulation. Curr. Hypertens. Rep. 2017, 19, 25. [CrossRef] [PubMed]
16. Jansson, T.; Powell, T.L. Role of placental nutrient sensing in developmental programming. Clin. Obstet. Gynecol. 2013, 56, 591–601. [CrossRef] [PubMed]
17. Tain, Y.L.; Hsu, C.N. Interplay between oxidative stress and nutrient sensing signaling in the developmental origins of cardiovascular disease. Int. J. Mol. Sci. 2017, 18, 841. [CrossRef] [PubMed]
18. Di Luccia, B.; Crescenzo, R.; Mazzoli, A.; Cigliano, L.; Venditti, P.; Walser, J.C.; Widmer, A.; Baccigalupi, L.; Ricca, E.; Iossa, S. Rescue of fructose-induced metabolic syndrome by antibiotics or faecal transplantation in a rat model of obesity. PLoS ONE 2015, 10, e0134893. [CrossRef] [PubMed]
19. Tain, Y.L.; Lee, W.C.; Wu, K.L.H.; Leu, S.; Chan, J.Y.H. Resveratrol prevents the development of hypertension programmed by maternal plus post-weaning high-fructose consumption through modulation of oxidative stress, nutrient-sensing signals, and gut microbiota. Mol. Nutr. Food Res. 2018, 62, e1800066. [CrossRef] [PubMed]
20. Kim, M.; Shin, H.K. The water-soluble extract of chicory influences serum and liver lipid concentrations, cecal short-chain fatty acid concentrations and fecal lipid excretion in rats. J. Nutr. 1998, 128, 1731–1736. [CrossRef] [PubMed]
21. De Waard, R.; Garssen, J.; Bokken, G.C.; Vos, J.G. Antagonistic activity of Lactobacillus casei strain shirota against gastrointestinal Listeria monocytogenes infection in rats. Int. J. Food Microbiol. 2002, 73, 93–100. [CrossRef]
22. Karimi, G.; Sabran, M.R.; Jamaluddin, R.; Parvaneh, K.; Mohtarrudin, N.; Ahmad, Z.; Khazaai, H.; Khodavandi, A. The anti-obesity effects of Lactobacillus casei strain Shirota versus Orlistat on high fat diet-induced obese rats. Food Nutr. Res. 2015, 59, 29273. [CrossRef] [PubMed]
23. Grigore, D.; Ojeda, N.B.; Alexander, B.T. Sex differences in the fetal programming of hypertension. Gend. Med. 2008, 5, S121–S132. [CrossRef] [PubMed]
24. Tain, Y.L.; Lee, C.T.; Chan, J.Y.; Hsu, C.N. Maternal melatonin or N-acetylcysteine therapy regulates hydrogen sulfide-generating pathway and renal transcriptome to prevent prenatal N(G)-Nitro-L-arginine-methyl ester (L-NAME)-induced fetal programming of hypertension in adult male offspring. Am. J. Obstet. Gynecol. 2016, 215, 636. [CrossRef] [PubMed]
25. Tain, Y.L.; Chan, J.Y.; Hsu, C.N. Maternal fructose intake affects transcriptome changes and programmed hypertension in offspring in later life. Nutrients 2016, 8, 757. [CrossRef] [PubMed]
26. Dong, J.Y.; Szeto, I.M.; Makinen, K.; Gao, Q.; Wang, J.; Qin, L.Q.; Zhao, Y. Effect of probiotic fermented milk on blood pressure: A meta-analysis of randomised controlled trials. Br. J. Nutr. 2013, 110, 1188–1194. [CrossRef] [PubMed]
27. De Wiele, T.V.; Boon, N.; Possemiers, S.; Jacobs, H.; Verstraete, W. Prebiotic effects of chicory inulin in the simulator of the human intestinal microbial ecosystem. FEMS Microbiol. Ecol. 2004, 51, 143–153. [CrossRef] [PubMed]
28. Tain, Y.L.; Lee, W.C.; Wu, K.; Leu, S.; Chan, J.Y.H. Maternal high fructose intake increases the vulnerability to post-weaning high-fat diet induced programmed hypertension in male offspring. Nutrients 2018, 10, 56. [CrossRef] [PubMed]
29. Veličković, N.; Teofilović, A.; Ilić, D.; Djordjevic, A.; Vojnović Milutinović, D.; Petrović, S.; Preitner, F.; Tappy, L.; Matić, G. Modulation of hepatic inflammation and energy-sensing pathways in the rat liver by high-fructose diet and chronic stress. Eur. J. Nutr. 2018. [CrossRef] [PubMed]
30. Tain, Y.L.; Hsu, C.N. AMP-activated protein kinase as a reprogramming strategy for hypertension and kidney disease of developmental origin. Int. J. Mol. Sci. 2018, 19, 1744. [CrossRef] [PubMed]
31. Chakraborti, C.K. New-found link between microbiota and obesity. World J. Gastrointest. Pathophysiol. 2015, 6, 110–119. [CrossRef] [PubMed]
32. Cani, P.D.; de Vos, W.M. Next-Generation Beneficial Microbes: The Case of Akkermansia muciniphila. Front. Microbiol. 2017, 8, 1765. [CrossRef] [PubMed]
33. Gorvitovskaia, A.; Holmes, S.P.; Huse, S.M. Interpreting Prevotella and Bacteroides as biomarkers of diet and lifestyle. Microbiome 2016, 4, 15. [CrossRef] [PubMed]
34. Hjorth, M.F.; Roager, H.M.; Larsen, T.M.; Poulsen, S.K.; Licht, T.R.; Bahl, M.I.; Zohar, Y.; Astrup, A. Pre-treatment microbial Prevotella-to-Bacteroides ratio, determines body fat loss success during a 6-month randomized controlled diet intervention. Int. J. Obes. 2018, 42, 580–583. [CrossRef] [PubMed]
35. Lee, W.C.; Wu, K.L.H.; Leu, S.; Tain, Y.L. Translational insights on developmental origins of metabolic syndrome: Focus on fructose consumption. Biomed. J. 2018, 41, 96–101. [CrossRef] [PubMed]
36. Gomez-Arango, L.F.; Barrett, H.L.; McIntyre, H.D.; Callaway, L.K.; Morrison, M.; Dekker Nitert, M. SPRING Trial Group. Connections between the gut microbiome and metabolic hormones in early pregnancy in overweight and obese women. Diabetes 2016, 65, 2214–2223. [CrossRef] [PubMed]
37. Belzer, C.; Gerber, G.K.; Roeselers, G.; Delaney, M.; DuBois, A.; Liu, Q.; Belavusava, V.; Yeliseyev, V.; Houseman, A.; Onderdonk, A.; et al. Dynamics of the microbiota in response to host infection. PLoS ONE 2014, 9, e95534. [CrossRef] [PubMed]
38. Santisteban, M.M.; Qi, Y.; Zubcevic, J.; Kim, S.; Yang, T.; Shenoy, V.; Cole-Jeffrey, C.T.; Lobaton, G.O.; Stewart, D.C.; Rubiano, A.; et al. Hypertension-Linked pathophysiological alterations in the gut. Circ. Res. 2017, 120, 312–323. [CrossRef] [PubMed]